北京市样本医院1996～2005年全身用抗菌药品采购价格趋势研究  

Study of the Antibacterials Purchase Price Trends from 1996 to 2005 of Beijing Sample Hospitals

作　　者：倪钎[1] 韩晟[1] 乔杰[2] 王海燕[2] 江滨[1] 胡茵[2] 史录文[1] 

机构地区：[1]北京大学医学部北京大学医药管理国际研究中心,北京100083 [2]中国药学会科技开发中心

出　　处：《中国药事》2007年第10期801-804,共4页Chinese Pharmaceutical Affairs

摘　　要：全身用抗菌药品是我国临床使用金额最大的药品类别,也是受到国家价格干预最多的类别。本文将价格指数应用于药品采购价格的分析,建立了分析药品采购价格总体变动的分析方法,并抽取了北京市12家医院1996-2005年全身用抗菌药品的采购记录进行分析。结果表明,全身用抗菌药品的价格十年来不断下降,但由于药品临床使用结构的变化,这类药品同期的加权平均采购价格仍然不断攀升。这提示我们单纯采取降价措施不足以控制药品费用,只有在控制已上市药品的价格的同时,严格制定新药的价格,并加强对药品临床使用的经济约束才能使费用负担得到有效控制。As the largest drug category used in China, ＂Antibacterials For Systemic Use＂ are also the category whose price been cut most frequently by government in recent years. Basing on price index theory, this paper establishes methods to describe drug price trends, and then applies these methods to analysis the purchasing records from 1996 to 2005 of 12 samples hospital in Beijing. It is found that： as a result of price cuts, the Laspeyres Price Index of antibacterials declined over the period of analysis. On the contrast, the Weighed Average Price of these drugs still rises dramatically over the same time. Findings illustrate the potential pitfalls of cost-management strategies that focus primarily on price, and suggest that government should strengthen measures on new drug pricing and cost control of drug utility.

关 键 词：药品价格 价格指数 加权平均 药品费用 

分 类 号：R197.322[医药卫生—卫生事业管理]